FindTrial
Sign In

A clinical trail to study the significance of serum prostrate specific antigen in breast cancer patients In belagavi , Karnataka - A one year observational study .

A STUDY OF CLINICAL SIGNIFIANCE OF SERUM PROSTATE SPECIFIC ANTIGEN IN BREAST CANCER PATIENTS- A ONE YEAR OBSERVATIONAL STUDY. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/08/092485
Enrollment
24
Registered
2025-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: Nil: Nil Control Intervention1: nil: nil

Sponsors

Dr Gaddam Rishitha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Female patients confirmed to have invasive breast cancer and those willing to give consent for the same .

Exclusion criteria

Exclusion criteria: Patients who denied the procedure . Patients who present with a lump in the breast whose tissue diagnosis revealed they were benign . Patients with Ovarian pathologies . Patients with uterine pathologies Immunocompromised patients

Design outcomes

Primary

MeasureTime frame
To compare serum Prostrate specific antigen values in breast cancer patients and healthy femalesTimepoint: Preoperative - with in 8 weeks from surgery—

Secondary

MeasureTime frame
To know the significance of serum Prostrate specific antigen in breast cancer patients .Timepoint: Preoperative , within 8 weeks from surgery—

Countries

India

Contacts

Public ContactDr Ramesh S Koujalagi

KLE University Jawaharlal Nehru Medical College

drrameshkoujalagi@gmail.com8970738515

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026